@2024 Afarand., IRAN
ISSN: 2252-0805 The Horizon of Medical Sciences 2015;21(2):129-134
ISSN: 2252-0805 The Horizon of Medical Sciences 2015;21(2):129-134
Effect of Coriander Fruit on Clinical Course of Migraine Patients: A Comparison between Random Effect and Transition Models
ARTICLE INFO
Article Type
Original ResearchAuthors
Mansouri A. (1)Zayeri F. (*)
Baghestani A.R. (1)
Ghorbanifar Z. (2)
Delavar Kasmaei H. (3)
Sheidaei A. (1)
(*) “Proteomics Research Center” and “Department of Biostatistics, Faculty of Paramedical Sciences”, Shahid Beheshti University of Medical Sciences, Tehran, Iran
(1) Biostatistics Department, Paramedical Sciences Faculty, Shahid Beheshti University of Medical Sciences, Tehran, Iran
(2) Traditional Medicine Department, Shahid Beheshti University of Medical Sciences, Tehran, Iran
(3) Neurology Department, Medicine Faculty, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Correspondence
Address: Department of Biostatistics, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Qods Square, Darband Street, Tehran, Iran. Postal Code: 1971653313Phone: +982122707347
Fax: +982122707347
fzayeri@gmail.com
Article History
Received: March 5, 2015Accepted: May 22, 2015
ePublished: June 20, 2015
ABSTRACT
Aims
Among all types of headache, migraine is the third most prevalent disorder and seventh common cause of disability. In Old Persian medical literature, Coriander fruit have been introduced as a treatment of headache. The aim of this study was exploring the effect of Coriander fruit on severity and duration of migraine attacks.
Materials & Methods This randomized triple-blind, placebo-controlled clinical trial was conducted in the neurology clinic of Shohadaye Tajrish hospital in Tehran. Based on sample size formula for longitudinal data, a total number of 66 patients were randomly assigned into intervention and control groups. Intervention group received common medicine plus Coriander fruit and the control group received common medicine plus placebo and both were followed during four weeks after intervention. For analyzing the data, random effect and transition models were utilized and the results were compared using Akaike criteria.
Findings The average of attacks duration in the intervention group was 4.27 hours less than the control group (p<0.001). Also, mean severity of migraine attacks in the intervention group was 2.81 (based on VAS scale) less than control group (p<0.001).
Conclusion Coriander fruit reduces the duration and severity of migraine attacks. Also, considering the duration and severity of last migraine attacks is necessary for prediction.
Materials & Methods This randomized triple-blind, placebo-controlled clinical trial was conducted in the neurology clinic of Shohadaye Tajrish hospital in Tehran. Based on sample size formula for longitudinal data, a total number of 66 patients were randomly assigned into intervention and control groups. Intervention group received common medicine plus Coriander fruit and the control group received common medicine plus placebo and both were followed during four weeks after intervention. For analyzing the data, random effect and transition models were utilized and the results were compared using Akaike criteria.
Findings The average of attacks duration in the intervention group was 4.27 hours less than the control group (p<0.001). Also, mean severity of migraine attacks in the intervention group was 2.81 (based on VAS scale) less than control group (p<0.001).
Conclusion Coriander fruit reduces the duration and severity of migraine attacks. Also, considering the duration and severity of last migraine attacks is necessary for prediction.
CITATION LINKS
[1]Balaban H, Semiz M, Şentürk IA, Kavakçı Ö, Cınar Z, Dikici A, et al. Migraine prevalence, alexithymia, and post-traumatic stress disorder among medical students in Turkey. J Headache Pain. 2012;13(6):459-67.
[2]Nazari F, Safavi M, Mahmudi M. Migraine and its relation with lifestyle in women. Pain Pract. 2010;10(3):228-34.
[3]Afshinmajd S, Davati A, Akbari F. The effects of body mass index on the treatment of the patients with migraine headaches. Iran J Neurol. 2011;10(3-4):35-8.
[4]Lipton RB, Serrano D, Holland S, Fanning KM, Reed ML, Buse DC. Barriers to the diagnosis and treatment of migraine: Effects of sex, income, and headache features. Headache. 2013;53(1):81-92.
[5]Liu R, Yu S, He M, Zhao G, Yang X, Qiao X, et al. Health-care utilization for primary headache disorders in China: A population-based door-to-door survey. J Headache Pain. 2013;14(1):47.
[6]Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-96.
[7]Zencirci B. Comparison of the effects of dietary factors in the management and prophylaxis of migraine. J Pain Res. 2010;3:125-30.
[8]Rasmussen BK. Epidemiology of headache. Cephalalgia. 2001;21(7):774-7.
[9]Shahbeigi S, Fereshtehnejad SM, Mohammadi N, Golmakani MM, Tadayyon S, Jalilzadeh G, et al. Epidemiology of headaches in Tehran urban area: A population-based cross-sectional study in district 8, year 2010. Neurol Sci. 2013;34(7):1157-66.
[10]Wang S-J, Chen P-K, Fuh J-L. Comorbidities of migraine. Front Neurol. 2010;1:16.
[11]Durham P, Papapetropoulos S. Biomarkers associated with migraine and their potential role in migraine management. Headache. 2013;53(8):1262-77.
[12]Tajmirriahi M, Sohelipour M, Basiri K, Shaygannejad V, Ghorbani A, Saadatnia M. The effects of sodium valproate with fish oil supplementation or alone in migraine prevention: A randomized single-blind clinical trial. Iran J Neurol. 2012;11(1):21-4.
[13]Barbanti P, Aurilia C, Egeo G, Fofi L. Migraine prophylaxis: What is new and what we need?. Neurol Sci. 2011;32 Suppl 1:S111-5.
[14]Ghorbanifar Z, Kasmaei HD, Minaei B, Rezaeizadeh H, Zayeri F. Types of nasal delivery drugs and medications in iranian traditional medicine to treatment of headache. Iran Red Crescent Med J. 2014;16(6):e15935.
[15]Pal SK, Shukla Y. Herbal medicine: Current status and the future. Asian Pac J Cancer Prev. 2003;4(4):281-8.
[16]Rahimi R, Shams Ardekani MR, Farjadmand F. Innovations and experiences of Hakim Seyed Mohammad Momen Tonekaboni in Tohfe-al Momenin. 2011;1(2):165-84. [Persian]
[17]Ansari M, Rafiee K, Fallah MS, Emamgholipour S. Migraine: Molecular basis and herbal medicine. In: Chen KS, editor. Advanced topics in neurological disorders. Rijeka, Croatia: InTECH; 2012.
[18]Batista PA, Werner MF, Oliveira EC, Burgos L, Pereira P, Brum LF, et al. The antinociceptive effect of (-)-linalool in models of chronic inflammatory and neuropathic hypersensitivity in mice. J Pain. 2010;11(11):1222-9.
[19]Heidari M, Aghili M, Soltaninezhad E. Evaluation of anti-inflammatory and analgesic effects of Coriandrum sativum extract in mice. J Qazvin Univ Med Sci. 2005;8(4):8-13. [Persian]
[20]Pathan AR, Kothawade KA, Logade MN. Anxiolytic and analgesic effect of seeds of Coriandrum sativum linn. Int J Res Pharm Chem. 2011;1(4):1087-99.
[21]Sonika G, Manubala R, Deepak J. Comparative studies on anti-inflammatory activity of Coriandrum sativum, Datura stramonium and Azadirachta indica. Asian J Exp Biol Sci. 2010;1(1):151-4.
[22]Taherian AA, Vafaei AA, Ameri J. Opiate system mediate the antinociceptive effects of Coriandrum sativum in mice. Iran J Pharm Res. 2012;11(2):679-88.
[23]Schlesselman JJ. Planning a longitudinal study: I. Sample size determination. J Chronic Dis. 1973;26(9):553-60.
[24]Fitzmaurice GM, Laird NM, Rotnitzky AG. Regression models for discrete longitudinal responses. Stat Sci. 1993;8(3):284-99.
[25]Ware JH. Linear models for the analysis of longitudinal studies. Am Stat. 1985;39(2):95-101.
[26]Funatogawa I, Funatogawa T. An autoregressive linear mixed effects model for the analysis of unequally spaced longitudinal data with dose‐modification. Stat Med. 2012;31(6):589-99.
[27]Kazemi I, Crouchley R. Modelling the initial conditions in dynamic regression models of panel data with random effects. Contrib Econ Anal. 2006;274:91-117.
[28]Mansourian M, Kazemnejad A, Kazemi I, Zayeri F, Soheilian M. Bayesian analysis of longitudinal ordered data with flexible random effects using McMC: Application to diabetic macular Edema data. J Appl Stat. 2012;39(5):1087-100.
[29]Diener HC, Limmroth V. Medication-overuse headache: A worldwide problem. Lancet Neurol. 2004;3(8):475-83.
[30]Fritsche G, Diener HC. Medication overuse headaches: What is new?. Expert opin drug saf. 2002;1(4):331-8.
[31]Gilmore B, Michael M. Treatment of acute migraine headache. Am Fam Physician. 2011;83(3):271-80.
[32]Modi S, Lowder DM. Medications for migraine prophylaxis. Am Fam Physician. 2006;73(1):72-8.
[33]Bianchi A, Salomone S, Caraci F, Pizza V, Bernardini R, D'Amato CC. Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis. Vitam Horm. 2004;69:297-312.
[34]Lee MS, Ernst E. Acupuncture for pain: An overview of Cochrane reviews. Chin J Integr Med. 2011;17(3):187-9.
[35]Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: A summary and comparison with other recent clinical practice guidelines. Headache. 2012;52(6):930-45.
[36]Rios J, Passe MM. Evidenced‐based use of botanicals, minerals, and vitamins in the prophylactic treatment of migraines. J Am Acad Nurse Pract. 2004;16(6):251-6.
[37]Linck VM, da Silva AL, Figueiró M, Piato AL, Herrmann AP, Dupont Birck F, et al. Inhaled linalool-induced sedation in mice. Phytomedicine. 2009;16(4):303-7.
[38]Emamghoreishi M, Heidari Hamedani G. Sedative-hypnotic activity of extracts and essential oil of coriander seeds. Iran J Med Sci. 2006;31(1):22-7.
[39]Engstrøm M, Hagen K, Bjørk M, Gravdahl GB, Sand T. Sleep-related and non-sleep-related migraine: Interictal sleep quality, arousals and pain thresholds. J Headache Pain. 2013;14:68.
[40]Freedom T, Evans RW. Headache and sleep. Headache. 2013;53(8):1358-66.
[2]Nazari F, Safavi M, Mahmudi M. Migraine and its relation with lifestyle in women. Pain Pract. 2010;10(3):228-34.
[3]Afshinmajd S, Davati A, Akbari F. The effects of body mass index on the treatment of the patients with migraine headaches. Iran J Neurol. 2011;10(3-4):35-8.
[4]Lipton RB, Serrano D, Holland S, Fanning KM, Reed ML, Buse DC. Barriers to the diagnosis and treatment of migraine: Effects of sex, income, and headache features. Headache. 2013;53(1):81-92.
[5]Liu R, Yu S, He M, Zhao G, Yang X, Qiao X, et al. Health-care utilization for primary headache disorders in China: A population-based door-to-door survey. J Headache Pain. 2013;14(1):47.
[6]Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-96.
[7]Zencirci B. Comparison of the effects of dietary factors in the management and prophylaxis of migraine. J Pain Res. 2010;3:125-30.
[8]Rasmussen BK. Epidemiology of headache. Cephalalgia. 2001;21(7):774-7.
[9]Shahbeigi S, Fereshtehnejad SM, Mohammadi N, Golmakani MM, Tadayyon S, Jalilzadeh G, et al. Epidemiology of headaches in Tehran urban area: A population-based cross-sectional study in district 8, year 2010. Neurol Sci. 2013;34(7):1157-66.
[10]Wang S-J, Chen P-K, Fuh J-L. Comorbidities of migraine. Front Neurol. 2010;1:16.
[11]Durham P, Papapetropoulos S. Biomarkers associated with migraine and their potential role in migraine management. Headache. 2013;53(8):1262-77.
[12]Tajmirriahi M, Sohelipour M, Basiri K, Shaygannejad V, Ghorbani A, Saadatnia M. The effects of sodium valproate with fish oil supplementation or alone in migraine prevention: A randomized single-blind clinical trial. Iran J Neurol. 2012;11(1):21-4.
[13]Barbanti P, Aurilia C, Egeo G, Fofi L. Migraine prophylaxis: What is new and what we need?. Neurol Sci. 2011;32 Suppl 1:S111-5.
[14]Ghorbanifar Z, Kasmaei HD, Minaei B, Rezaeizadeh H, Zayeri F. Types of nasal delivery drugs and medications in iranian traditional medicine to treatment of headache. Iran Red Crescent Med J. 2014;16(6):e15935.
[15]Pal SK, Shukla Y. Herbal medicine: Current status and the future. Asian Pac J Cancer Prev. 2003;4(4):281-8.
[16]Rahimi R, Shams Ardekani MR, Farjadmand F. Innovations and experiences of Hakim Seyed Mohammad Momen Tonekaboni in Tohfe-al Momenin. 2011;1(2):165-84. [Persian]
[17]Ansari M, Rafiee K, Fallah MS, Emamgholipour S. Migraine: Molecular basis and herbal medicine. In: Chen KS, editor. Advanced topics in neurological disorders. Rijeka, Croatia: InTECH; 2012.
[18]Batista PA, Werner MF, Oliveira EC, Burgos L, Pereira P, Brum LF, et al. The antinociceptive effect of (-)-linalool in models of chronic inflammatory and neuropathic hypersensitivity in mice. J Pain. 2010;11(11):1222-9.
[19]Heidari M, Aghili M, Soltaninezhad E. Evaluation of anti-inflammatory and analgesic effects of Coriandrum sativum extract in mice. J Qazvin Univ Med Sci. 2005;8(4):8-13. [Persian]
[20]Pathan AR, Kothawade KA, Logade MN. Anxiolytic and analgesic effect of seeds of Coriandrum sativum linn. Int J Res Pharm Chem. 2011;1(4):1087-99.
[21]Sonika G, Manubala R, Deepak J. Comparative studies on anti-inflammatory activity of Coriandrum sativum, Datura stramonium and Azadirachta indica. Asian J Exp Biol Sci. 2010;1(1):151-4.
[22]Taherian AA, Vafaei AA, Ameri J. Opiate system mediate the antinociceptive effects of Coriandrum sativum in mice. Iran J Pharm Res. 2012;11(2):679-88.
[23]Schlesselman JJ. Planning a longitudinal study: I. Sample size determination. J Chronic Dis. 1973;26(9):553-60.
[24]Fitzmaurice GM, Laird NM, Rotnitzky AG. Regression models for discrete longitudinal responses. Stat Sci. 1993;8(3):284-99.
[25]Ware JH. Linear models for the analysis of longitudinal studies. Am Stat. 1985;39(2):95-101.
[26]Funatogawa I, Funatogawa T. An autoregressive linear mixed effects model for the analysis of unequally spaced longitudinal data with dose‐modification. Stat Med. 2012;31(6):589-99.
[27]Kazemi I, Crouchley R. Modelling the initial conditions in dynamic regression models of panel data with random effects. Contrib Econ Anal. 2006;274:91-117.
[28]Mansourian M, Kazemnejad A, Kazemi I, Zayeri F, Soheilian M. Bayesian analysis of longitudinal ordered data with flexible random effects using McMC: Application to diabetic macular Edema data. J Appl Stat. 2012;39(5):1087-100.
[29]Diener HC, Limmroth V. Medication-overuse headache: A worldwide problem. Lancet Neurol. 2004;3(8):475-83.
[30]Fritsche G, Diener HC. Medication overuse headaches: What is new?. Expert opin drug saf. 2002;1(4):331-8.
[31]Gilmore B, Michael M. Treatment of acute migraine headache. Am Fam Physician. 2011;83(3):271-80.
[32]Modi S, Lowder DM. Medications for migraine prophylaxis. Am Fam Physician. 2006;73(1):72-8.
[33]Bianchi A, Salomone S, Caraci F, Pizza V, Bernardini R, D'Amato CC. Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis. Vitam Horm. 2004;69:297-312.
[34]Lee MS, Ernst E. Acupuncture for pain: An overview of Cochrane reviews. Chin J Integr Med. 2011;17(3):187-9.
[35]Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: A summary and comparison with other recent clinical practice guidelines. Headache. 2012;52(6):930-45.
[36]Rios J, Passe MM. Evidenced‐based use of botanicals, minerals, and vitamins in the prophylactic treatment of migraines. J Am Acad Nurse Pract. 2004;16(6):251-6.
[37]Linck VM, da Silva AL, Figueiró M, Piato AL, Herrmann AP, Dupont Birck F, et al. Inhaled linalool-induced sedation in mice. Phytomedicine. 2009;16(4):303-7.
[38]Emamghoreishi M, Heidari Hamedani G. Sedative-hypnotic activity of extracts and essential oil of coriander seeds. Iran J Med Sci. 2006;31(1):22-7.
[39]Engstrøm M, Hagen K, Bjørk M, Gravdahl GB, Sand T. Sleep-related and non-sleep-related migraine: Interictal sleep quality, arousals and pain thresholds. J Headache Pain. 2013;14:68.
[40]Freedom T, Evans RW. Headache and sleep. Headache. 2013;53(8):1358-66.